131 related articles for article (PubMed ID: 4622605)
1. [Pseudomonas aeruginosa infections].
Tanaka E
Naika; 1972; 29(2):286-90. PubMed ID: 4622605
[No Abstract] [Full Text] [Related]
2. [Sensitivity in vitro to antibiotics and chemotherapeutic agents in various hospital strains of Pseudomonas aeruginosa].
Bertaggia A; De Negri M
Boll Ist Sieroter Milan; 1974; 50(1):45-53. PubMed ID: 4204863
[No Abstract] [Full Text] [Related]
3. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
Torné J; García Flores A; Tomás S; Serrano R
Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961
[No Abstract] [Full Text] [Related]
4. [In vitro/in vivo discrepancy of antibiotic activity against Pseudomonas aeruginosa].
Gerber AU
Fortschr Med; 1985 Sep; 103(34):807-10. PubMed ID: 3935553
[No Abstract] [Full Text] [Related]
5. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
[No Abstract] [Full Text] [Related]
6. [Trend of therapy in Pseudomonas aeruginosa infections].
Jannuzzi C; Tassara A
G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
[No Abstract] [Full Text] [Related]
7. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
Výmola F; Jedlicková Z
Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
[No Abstract] [Full Text] [Related]
8. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
9. Colistin: an antimicrobial for the 21st century?
Stein A; Raoult D
Clin Infect Dis; 2002 Oct; 35(7):901-2. PubMed ID: 12228836
[No Abstract] [Full Text] [Related]
10. Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.
Scheetz MH; Esterly JS; Malczynski M; Postelnick M; Qi C
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):465-7. PubMed ID: 19394788
[No Abstract] [Full Text] [Related]
11. [A comparative study of cephotaxime and other antimicrobial agents in relationship to Pseudomonas aeruginosa (author's transl)].
García Martos P; Rodríguez Sarmiento MT; García Herruzo J; Fernández Gutiérrez del Alamo C; Romera Cano MA; Martínez País Romaní R
Med Clin (Barc); 1982 Feb; 78(4):148-51. PubMed ID: 6279982
[No Abstract] [Full Text] [Related]
12. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
13. [Antibiotic, triphenylmethane dyes and boric acid in increased occurrence of Pseudomonas aeruginosa].
Möhlenbeck F
Z Haut Geschlechtskr; 1970 Apr; 45(8):329-32. PubMed ID: 4327229
[No Abstract] [Full Text] [Related]
14. [Effective agents against Pseudomonas pyocyanea (proceedings)].
Meyer-Rohn J
Z Hautkr; 1976; 51 Suppl 2():106-8. PubMed ID: 827860
[No Abstract] [Full Text] [Related]
15. Should we be afraid of the Green Monster?
Rumbaugh K
Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
[No Abstract] [Full Text] [Related]
16. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
17. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Pseudomonas aeruginosa infections].
Klastersky J
Acta Clin Belg Suppl; 1971; 7():75-8. PubMed ID: 5004796
[No Abstract] [Full Text] [Related]
19. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
20. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
